Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Lee Jackson | Jan 25, 2018 at 10:00 AM EST

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

With the market trading at very extended valuations, and the S&P 500 on the longest streak ever without a 5%…

Chris Lange | Jan 21, 2018 at 10:20 AM EST

Netflix, Ford and More Big Earnings to Watch For This Week

24/7 Wall St. has put together a preview of Netflix, Ford, AbbVie and other top companies reporting their latest quarterly…

Chris Lange | Jan 11, 2018 at 9:45 AM EST

Major Pharma Short Interest Takes a Plunge

The December 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 6, 2018 at 8:55 AM EST

20 More Biopharma Catalysts Coming in 2018

Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves…

Jon C. Ogg | Jan 4, 2018 at 9:20 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

The top analyst upgrades, downgrades and other research calls from Thursday include Alphabet, Avon, Bank of America, Intel, Roku, Snap…

Jon C. Ogg | Dec 28, 2017 at 11:20 AM EST

10 Things That Could Wreck the Bull Market in Stocks in 2018

Is it finally time to consider the old adage that "nothing lasts forever" for the bull market as we enter…

Chris Lange | Dec 28, 2017 at 10:25 AM EST

More and More Short Sellers Raising the Stakes in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Dec 12, 2017 at 10:40 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 27, 2017 at 10:55 AM EDT

Why AbbVie Won Big in Q3, and Can Keep Winning

AbbVie reported better-than-expected third-quarter before the markets opened on Friday due to strong sales of Humira and Imbruvica.

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Oct 22, 2017 at 10:45 AM EDT

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

At least eight large biotech and pharma outfits are scheduled to report their latest earnings and revenues this coming week.

Lee Jackson | Oct 19, 2017 at 8:30 AM EDT

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

These four top companies all have data that could move the shares the rest of this year and into 2018.…

1 … 20 21 22 23 24 … 38

AbbVie : ABBV

All AbbVie Articles

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Netflix, Ford and More Big Earnings to Watch For This Week

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

10 Things That Could Wreck the Bull Market in Stocks in 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

AbbVie : ABBV

All AbbVie Articles

SunTrust Bullish on Blue Chip Large-Cap Pharmaceuticals: 4 to Buy Now

Netflix, Ford and More Big Earnings to Watch For This Week

Major Pharma Short Interest Takes a Plunge

20 More Biopharma Catalysts Coming in 2018

Top Analyst Upgrades and Downgrades: Alphabet, Avon, Bank of America, Intel, Roku, Snap, Western Digital and Many More

10 Things That Could Wreck the Bull Market in Stocks in 2018

More and More Short Sellers Raising the Stakes in Major Pharma

Short Sellers Can’t Make Up Their Minds on Major Pharma

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Why AbbVie Won Big in Q3, and Can Keep Winning

Short Sellers Hike Bets in Major Pharma

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It